Fatty Liver Terminated Phase 4 Trials for Peginterferon alfa-2a (DB00008)
Also known as: Liver fatty / Infiltration fatty liver / Fatty liver metamorphosis / Liver fatty metamorphosis / Metamorphosis fatty liver / Liver fatty degeneration / Degeneration fatty liver / Liver fatty infiltration / Fatty liver infiltration / Steatosis of liver (disorder) / Liver fatty change / Steatosis hepatic / Hepatic steatosis / Steatohepatitis (disorder) / Steatohepatitis
Indication | Status | Phase |
---|---|---|
DBCOND0028942 (Fatty Liver) | Terminated | 4 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT00274495 | Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver | Treatment |